Development of inhibitors of reverse transcriptase and protease as therapeutics against HIV infection.
Mitsuya
H
H
Experimental Retrovirology Section, National Cancer Institute, Bethesda, Maryland.
D000595:Amino Acid Sequence; D000998:Antiviral Agents / Q000627:therapeutic use*; D015195:Drug Design; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D008969:Molecular Sequence Data; D018894:Reverse Transcriptase Inhibitors
D000998:Antiviral Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors